VitaNova Life Sciences Corporation Selling Expense
VitaNova Life Sciences Corporation (VNOV) reported Selling Expense of $2.90 thousand for the 12-month period ending 2026-04-30, per its 10-K filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2026-07-29
- VitaNova Life Sciences Corporation selling expense for the quarter ending 2026-04-30 was $0.00, a 100.00% decline year-over-year.
- VitaNova Life Sciences Corporation selling expense for the quarter ending 2026-01-31 was $0.00, a 100.00% decline year-over-year.
- VitaNova Life Sciences Corporation selling expense for the quarter ending 2025-10-31 was $2.90K, a 1723.90% increase year-over-year.
- VitaNova Life Sciences Corporation selling expense for the quarter ending 2025-07-31 was $0.00, a 100.00% decline year-over-year.
- VitaNova Life Sciences Corporation selling expense for fiscal 2026 was $2.90K, a 62.17% decline from fiscal 2025.
- VitaNova Life Sciences Corporation selling expense for fiscal 2025 was $7.67K, a 66.20% decline from fiscal 2024.
- VitaNova Life Sciences Corporation selling expense for fiscal 2024 was $22.68K.
- VitaNova Life Sciences Corporation selling expense for fiscal 2023 was $0.00.
| Period end | Selling Expense 3 month | Selling Expense 6 month | Selling Expense 9 month | Selling Expense 12 month |
|---|---|---|---|---|
| 2026-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $0.00 derived: sum of 2 quarters · filed 2026-07-29 | $2.90K derived: sum of 3 quarters · filed 2026-07-29 | $2.90K 10-K · filed 2026-07-29 |
| 2026-01-31 | $0.00 10-Q · filed 2026-03-16 | $2.90K derived: sum of 2 quarters · filed 2026-03-16 | $2.90K 10-Q · filed 2026-03-16 | $3.08K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-10-31 | $2.90K 10-Q · filed 2025-12-15 | $2.90K 10-Q · filed 2025-12-15 | $3.08K derived: sum of 3 quarters · filed 2026-07-29 | $3.38K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-07-31 | $0.00 10-Q · filed 2025-09-12 | $177.00 derived: sum of 2 quarters · filed 2026-07-29 | $477.00 derived: sum of 3 quarters · filed 2026-07-29 | $636.00 derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-04-30 | $177.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $477.00 derived: sum of 2 quarters · filed 2026-07-29 | $636.00 derived: sum of 3 quarters · filed 2026-07-29 | $7.67K 10-K · filed 2026-07-29 |
| 2025-01-31 | $300.00 10-Q · filed 2026-03-16 | $459.00 derived: sum of 2 quarters · filed 2026-03-16 | $7.49K 10-Q · filed 2026-03-16 | $30.17K derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-10-31 | $159.00 10-Q · filed 2025-12-15 | $7.19K 10-Q · filed 2025-12-15 | $29.87K derived: sum of 3 quarters · filed 2025-12-15 | $29.87K derived: sum of 4 quarters · filed 2025-12-15 |
| 2024-07-31 | $7.03K 10-Q · filed 2025-09-12 | $29.71K derived: sum of 2 quarters · filed 2025-09-12 | $29.71K derived: sum of 3 quarters · filed 2025-09-12 | $29.71K derived: sum of 4 quarters · filed 2025-09-12 |
| 2024-04-30 | $22.68K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-24 | $22.68K derived: sum of 2 quarters · filed 2025-07-24 | $22.68K derived: sum of 3 quarters · filed 2025-07-24 | $22.68K 10-K · filed 2025-07-24 |
| 2024-01-31 | $0.00 10-Q · filed 2025-03-17 | $0.00 derived: sum of 2 quarters · filed 2025-03-17 | $0.00 10-Q · filed 2025-03-17 | |
| 2023-10-31 | $0.00 10-Q · filed 2024-12-13 | $0.00 10-Q · filed 2024-12-13 | ||
| 2023-07-31 | $0.00 10-Q · filed 2024-09-10 | |||
| 2023-04-30 | $0.00 10-K · filed 2024-07-29 |